Question 1

Who owns PHAR?

Accepted Answer

PHARMING GROUP (PHAR) is held by 5 institutional investors that disclose positions via SEC 13F filings. The largest disclosed holder is MORGAN STANLEY as of Q1 2026.

Question 2

Are institutions buying or selling PHAR?

Accepted Answer

In Q1 2026, 2 institutions opened or increased positions in PHARMING GROUP while 5 reduced or exited — a net selling quarter.

Question 3

What is the Smart Money Verdict on PHAR?

Accepted Answer

The Smart Money Verdict combines four independent sources (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for PHARMING GROUP.

Question 4

How many hedge funds hold PHAR?

Accepted Answer

5 institutional investors report holding PHARMING GROUP (PHAR) as of Q1 2026, based on SEC 13F filings.

Question 5

Is institutional money flowing into PHAR?

Accepted Answer

As of Q1 2026, tracked institutions in PHARMING GROUP show 2 buyers versus 5 sellers — net outflows.

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
MORGAN STANLEY	Increased	11,489(+49.2%)	$191,177	0.0%	-0.15%	21
CITADEL ADVISORS LLC	Decreased	10,189(-42.4%)	$169,545	0.0%	-17.55%	0
NewEdge Advisors, LLC	Decreased	2,150(-92.5%)	$35,777	0.0%	-8.26%	0
BNP PARIBAS FINANCIAL MARKETS	Decreased	400(-50.0%)	$6,656	0.0%	-15.90%	0
OSAIC HOLDINGS, INC.	New	128	$2,130	0.0%	-10.00%	18
MILLENNIUM MANAGEMENT LLC	Exited	0(-100.0%)	$360,203	0.0%	-8.39%	0
UBS Group AG	Exited	0(-100.0%)	$18	0.0%	-8.39%	0

PHARMING GROUP

Continue exploring

Other Healthcare stocks held by institutions